Drug Profile
PRO 98498
Alternative Names: HAE1; PRO98498Latest Information Update: 09 Aug 2011
Price :
$50
*
At a glance
- Originator Genentech
- Class Antiasthmatics
- Mechanism of Action IgE receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic asthma
Most Recent Events
- 09 Aug 2008 Discontinued - Phase-II for Allergic asthma in USA (SC)